Forte Biosciences is a US-based clinical-stage biopharmaceutical company that focuses on developing treatments for autoimmune diseases. Its principal program is called FB-102 and is aimed at targeting ailments such as vitiligo and alopecia areata. The company is based in Dallas, Texas.